- Investing Ideas
- /
- Belgian Pharmaceuticals & Biotech High Growth Potential Companies
Belgian Pharmaceuticals & Biotech High Growth Potential Companies
Results
3
0 new
Companies with a Future performance score of at least 3, ordered by Future performance score.
3 companies
argenx
Market Cap: €44.3b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€723.60
7D
-7.7%
1Y
19.4%
Hyloris Pharmaceuticals
Market Cap: €166.9m
Engages in the research, development, and manufacture of pharmaceutical products to address medical needs.
HYL
€5.96
7D
0.3%
1Y
1.4%
UCB
Market Cap: €45.2b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€238.10
7D
-4.1%
1Y
28.4%